Literature DB >> 22368904

Severe malaria in children: factors predictive of outcome and response to Quinine.

Saba Ahmed1, Faraz Adil, Talha Shahzad, Yusuf Yahiya.   

Abstract

OBJECTIVE: To identify clinical features of severe malaria and their association with adverse outcomes according to recently proposed WHO guidelines and observe treatment failure to Quinine.
METHODS: This descriptive study was performed at Civil Hospital Karachi from September 2007 to January 2008. Various clinical features and laboratory parameters were analyzed according to t WHO guidelines and treatment failure to anti-malarial drugs was recorded. Mean, frequencies, percentages and chi-square test were used for analysis. Statistical significance was defined as p-value < 0.05.
RESULTS: Total of 81 patients were enrolled in the study. Mean age of children was 5.5 +/- 3.4 years. Type of malaria infections that were seen included falciparum 46 (57%), mixed infection 26 (32%) and vivax 9 (11%). Frequent clinical features included splenomegaly (74%), multiple organ dysfunction (MOD) (70%), cerebral malaria (31%) and malnutrition (27%). Thrombocytopenia (86%) and severe anaemia (42%) were the common laboratory findings. Shock (p < 0.001), renal failure (p < 0.001), hepatic involvement (p < 0.002) and cerebral malaria (p < 0.002) emerged as strong predictors of complications. Fourteen out of 81 cases showed early treatment failure to Quinine.
CONCLUSION: Shock, renal failure, hepatic involvement and cerebral malaria are strongly associated with complications in severe malaria. MOD and malnutrition were identified as significant new clinical features present in severe malaria in this study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22368904

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  7 in total

1.  Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India.

Authors:  Virender Kumar Gehlawat; Vandana Arya; Jaya Shankar Kaushik; Geeta Gathwala
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

2.  The high risk of malarial recurrence in patients with Plasmodium-mixed infection after treatment with antimalarial drugs: a systematic review and meta-analysis.

Authors:  Aongart Mahittikorn; Frederick Ramirez Masangkay; Kwuntida Uthaisar Kotepui; Giovanni De Jesus Milanez; Manas Kotepui
Journal:  Parasit Vectors       Date:  2021-05-25       Impact factor: 3.876

3.  Malarial Hepatopathy in Children Visiting a Tertiary Healthcare Hospital in Karachi.

Authors:  Nathumal Maheshwari; Mehmood Shaikh; Rewa Chand; Hemandas Maheshwari; Mehrunnisa Yasir
Journal:  Cureus       Date:  2020-01-18

4.  Clinical and Lab profile of severe and uncomplicated malaria: A prospective study from Khuzdar Balochistan.

Authors:  Memoona Khan; Haider Nisar; Nuzhat Mushahid
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

5.  Treatment outcome and factors associated with mortality due to malaria in Munini District Hospital, Rwanda in 2016-2017: Retrospective cross-sectional study.

Authors:  François Hakizayezu; Jared Omolo; Emmanuel Biracyaza; Joseph Ntaganira
Journal:  Front Public Health       Date:  2022-08-09

6.  Five-Year Status of Malaria (a Disease Causing Anemia) in Yazd, 2008-2012.

Authors:  A Fattahi Bafghi; S A Pourmazar; F Shamsi
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22

7.  Methylene blue based device for pathogen reduction in human plasma.

Authors:  A Elikaei; S M Hosseini; Z Sharifi; H Latifi; H Nikbakht; H Mirshafiee; A Asadollahi
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.